Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer

by Berz, David, Raymond, Victoria M., Garst, Jordan H., Erlander, Mark G.
Published in Exp Hematol Oncol (2016)

Urine test for EGFR analysis in patients with non-small cell lung cancer

by Franovic, Aleksandra, Raymond, Victoria M., Erlander, Mark G., Reckamp, Karen L.
Published in J Thorac Dis (2017)

Gene expression profiling of the tumor microenvironment during breast cancer progression

by Ma, Xiao-Jun, Dahiya, Sonika, Richardson, Elizabeth, Erlander, Mark, Sgroi, Dennis C
Published 2009

Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification

by Erlander, Mark G., Ma, Xiao-Jun, Kesty, Nicole C., Bao, Lei, Salunga, Ranelle, Schnabel, Catherine A.
Published 2011

Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

by Greco, F. Anthony, Spigel, David R., Yardley, Denise A., Erlander, Mark G., Ma, Xiao-Jun, Hainsworth, John D.
Published 2010

TOGA: An automated parsing technology for analyzing expression of nearly all genes

by Sutcliffe, J. Gregor, Foye, Pamela E., Erlander, Mark G., Hilbush, Brian S., Bodzin, Leon J., Durham, Jayson T., Hasel, Karl W.
Published 2000

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

by Jankowitz, Rachel C, Cooper, Kristine, Erlander, Mark G, Ma, Xiao-Jun, Kesty, Nicole C, Li, Hongying, Chivukula, Mamatha, Brufsky, Adam
Published 2011

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer

by Giordano, Antonio, Liu, Yueying, Armeson, Kent, Park, Yeonhee, Ridinger, Maya, Erlander, Mark, Reuben, James, Britten, Carolyn, Kappler, Christiana, Yeh, Elizabeth, Ethier, Stephen
Published in PLoS One (2019)

Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli

by Peterson, Karin S., Huang, Jing-Feng, Zhu, Jessica, D’Agati, Vivette, Liu, Xuejun, Miller, Nancy, Erlander, Mark G., Jackson, Michael R., Winchester, Robert J.
Published 2004

High Expression of Stanniocalcin in Differentiated Brain Neurons

by Zhang, Ke-zhou, Westberg, Johan A., Paetau, Anders, von Boguslawsky, Kristina, Lindsberg, Perttu, Erlander, Mark, Guo, Hongqing, Su, Jeffrey, Olsen, Henrik S., Andersson, Leif C.
Published 1998

HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease

by Habel, Laurel A, Sakoda, Lori C, Achacoso, Ninah, Ma, Xiao-Jun, Erlander, Mark G, Sgroi, Dennis C, Fehrenbacher, Louis, Greenberg, Deborah, Quesenberry, Charles P
Published 2013

Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma

by Chen, Inna, Raymond, Victoria M., Geis, Jennifer A., Collisson, Eric A., Jensen, Benny V., Hermann, Kirstine L., Erlander, Mark G., Tempero, Margaret, Johansen, Julia S.
Published in Oncotarget (2017)

Single-Cell Microarray Analysis in Hippocampus CA1: Demonstration and Validation of Cellular Heterogeneity

by Kamme, Fredrik, Salunga, Ranelle, Yu, Jingxue, Tran, Da-Thao, Zhu, Jessica, Luo, Lin, Bittner, Anton, Guo, Hong-Qing, Miller, Nancy, Wan, Jackson, Erlander, Mark
Published in J Neurosci (2003)

DNA Microarrays of the Complex Human Cytomegalovirus Genome: Profiling Kinetic Class with Drug Sensitivity of Viral Gene Expression

by Chambers, James, Angulo, Ana, Amaratunga, Dhammika, Guo, Hongqing, Jiang, Ying, Wan, Jackson S., Bittner, Anton, Frueh, Klaus, Jackson, Michael R., Peterson, Per A., Erlander, Mark G., Ghazal, Peter
Published 1999

Prediction of late distant recurrence in estrogen receptor positive breast cancer patients: prospective comparison of the Breast Cancer Index (BCI), Oncotype DX recurrence score, a...

by Sgroi, Dennis C., Sestak, Ivana, Cuzick, Jack, Zhang, Yi, Schnabel, Catherine A., Schroeder, Brock, Erlander, Mark G., Dunbier, Anita, Sidhu, Kally, Lopez-Knowles, Elena, Goss, Paul E., Dowsett, Mitch
Published 2013

Development and validation of a 32-gene prognostic index for prostate cancer progression

by Wu, Chin-Lee, Schroeder, Brock E., Ma, Xiao-Jun, Cutie, Christopher J., Wu, Shulin, Salunga, Ranelle, Zhang, Yi, Kattan, Michael W., Schnabel, Catherine A., Erlander, Mark G., McDougal, W. Scott
Published 2013

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

by Husain, Hatim, Melnikova, Vladislava O., Kosco, Karena, Woodward, Brian, More, Soham, Pingle, Sandeep C., Weihe, Elizabeth, Park, Ben Ho, Tewari, Muneesh, Erlander, Mark G., Cohen, Ezra, Lippman, Scott M., Kurzrock, Razelle
Published in Clin Cancer Res (2017)

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

by Janku, Filip, Vibat, Cecile Rose T., Kosco, Karena, Holley, Veronica R., Cabrilo, Goran, Meric-Bernstam, Funda, Stepanek, Vanda M., Lin, Patrick P., Leppin, Lorieta, Hassaine, Latifa, Poole, Jason C., Kurzrock, Razelle, Erlander, Mark G.
Published 2014

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

by Sgroi, Dennis C., Chapman, Judy-Anne W., Badovinac-Crnjevic, T., Zarella, Elizabeth, Binns, Shemeica, Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Pritchard, Kathleen I., Han, Lei, Shepherd, Lois E., Goss, Paul E., Pollak, Michael
Published in Breast Cancer Res (2016)

BRAF(V600E) Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy

by Klempner, Samuel J., Gershenhorn, Bruce, Tran, Phu, Lee, Thomas K., Erlander, Mark G., Gowen, Kyle, Schrock, Alexa B., Morosini, Deborah, Ross, Jeffrey S., Miller, Vincent A., Stephens, Philip J., Ignatius Ou, Sai-Hong, Ali, Siraj M.
Published in Cancer Discov (2016)